Previous 10 | Next 10 |
home / stock / nmlsf / nmlsf news
U.S. FDA Approves Nova Mentis Orphan Drug Application Canada NewsWire Psilocybin Fragile X Syndrome Treatment VANCOUVER, BC , Nov. 2, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"...
Nova Mentis Earns Psilocybin Orphan Drug Designation in Europe for Fragile X Syndrome PR Newswire VANCOUVER, BC , Oct. 26, 2021 /PRNewswire/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology...
Nova Mentis Applies to US FDA for Psilocybin Orphan Drug Designation Fragile X Syndrome Treatment Canada NewsWire VANCOUVER, BC , Sept. 14, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF ) ("NOVA" or the "Company")...
Nova Mentis to Present at the H.C. Wainwright Global Investment Conference Canada NewsWire VANCOUVER, BC , Sept. 9, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and g...
Nova Mentis Expands Psilocybin Research Program Targets Obesity and Diabetes Canada NewsWire VANCOUVER, BC , Sept. 7, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and...
Nova Mentis Files Fragile X Orphan Drug Designation with European Medicines Agency Canada NewsWire VANCOUVER, BC , Aug. 12, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology compa...
Nova Mentis Files U.S. Patent Application for Psilocybin-Based Therapeutics Canada NewsWire VANCOUVER, BC , July 29, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and ...
Nova Mentis Appoints Dr. Stephen Glazer as Director and Chief Science Officer Canada NewsWire VANCOUVER, BC , July 15, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology co...
Nova Mentis Autism Clinical Study Approved by Canadian Institutional Review Board Canada NewsWire VANCOUVER, BC , June 23, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology compan...
Nova Mentis to Present at the H.C. Wainwright Psychedelics Conference Canada NewsWire VANCOUVER, BC, June 10, 2021 /CNW/ - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: LIBFF) ("NOVA" or the "Company"), a biotechnology company and global...
News, Short Squeeze, Breakout and More Instantly...
Nova Mentis Life Science Corp Company Name:
NMLSF Stock Symbol:
OTCMKTS Market:
Nova Mentis Life Science Corp Website:
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company") announces the appointment of Steve Loutskou to the Company's Board of Directors, effective February 23, 2024. Mr. Loutskou, a seas...
Vancouver, British Columbia--(Newsfile Corp. - November 3, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroin...
Vancouver, British Columbia--(Newsfile Corp. - August 30, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinf...